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Profound intellectual and multiple disabil-
ities
A B S T R A C T
Caregivers of persons with profound intellectual and multiple disabilities (PIMD) often
describe thequalityof thedailymovementsof thesepersons in termsofﬂexibilityor stiffness.
Objective outcomemeasures for ﬂexibility and stiffness aremuscle tone or level of spasticity.
Two instruments used to grade muscle tone and spasticity are the Modiﬁed Ashworth Scale
(MAS) and the Modiﬁed Tardieu Scale (MTS). To date, however, no research has been
performed to determine the psychometric properties of the MAS and MTS in persons with
PIMD. Therefore, the purpose of this study was to determine the feasibility, test–retest
reliability, and interrater reliability of the MAS andMTS in persons with PIMD.We assessed
35 participants on the MAS and MTS twice, ﬁrst for the test and second a week later for the
retest. Two observers performed the measurements. Feasibility was assessed based on the
percentage of successful measurements. Test–retest and interrater reliability were
determined by using the Wilcoxon signed rank test, intraclass correlation coefﬁcients
(ICC), Spearman’s correlation, and either limits of agreement (LOA) or quadraticallyweighted
kappa. The feasibility of the measurements was good, because an acceptable percentage of
successful measurements were performed. MAS measurements had substantial to almost
perfect quadraticallyweighted kappa (>0.8) and an acceptable ICC (>0.8) for both inter- and
intrarater reliability. However, MTS measurements had insufﬁcient ICCs, Spearman’s
correlations, and LOAs for both inter- and interrater reliability. Our data indicated that the
feasibility of the MAS and MTS for measuring muscle tone in persons with PIMD was good.
The MAS had sufﬁcient test–retest and interrater reliability; however, the MTS had an
insufﬁcient test–retest and interrater reliability in personswith PIMD. Thus, theMASmay be
agoodmethod for evaluating thequalityofdailymovements inpersonswithPIMD.Providing
test administrators with training and clear instructions will improve test reliability.
 2010 Elsevier Ltd. All rights reserved.
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1. Introduction
Persons with profound intellectual and multiple disabilities (PIMD) generally have very limited mobility, always use a
wheelchair (Van der Putten, Vlaskamp, Reynders, & Nakken, 2005), and often have a Gross Motor Function Classiﬁcation
System (GMFCS) level of IV or V (Palisano et al., 2000). Spasticity, dyskinesia, or ataxia with hypotony frequently occurs in
individuals in these GMFCS levels (Shevell, Dagenais, & Hall, 2009). Lance (1990) deﬁned spasticity as ‘‘a motor disorder,
characterised by a velocity-dependent increase in tonic stretch reﬂexes (muscle tone) with exaggerated tendon jerks,
resulting from hyper-excitability of the stretch reﬂex as one component of the upper motor neurone syndrome’’. Muscle
tonus or muscle tone is ‘‘the state of activity or tension of a muscle beyond that related to its physical properties, that is, its
active resistance to stretch. In skeletal muscle, tonus is dependent upon efferent innervation’’ (Stedman, 1999).
Persons with PIMD are at risk for a variety of limitations in daily functioning (Evenhuis, Sjoukes, Koot, & Kooijman, 2009),
such as inactivity, unsteadymovement, and diminished initiative. However, research into the quality of daily movements of
persons with PIMD is limited, and related knowledge is scarce. Caregivers of persons with PIMD often describe the quality of
daily movements in terms of ﬂexibility or stiffness. Objective outcomemeasures for ﬂexibility and stiffness are muscle tone
or level of spasticity.
Bohannon and Smith (1987) introduced theModiﬁed Ashworth Scale (MAS) as a scale for grading spasticity. TheMAS is a
clinical measure of muscle tone and a nominal-level measure of resistance to passive movement (Pandyan et al., 1999). The
reliability of the scale appears to be better for measuring muscle tone of upper limbs (Pandyan et al., 1999). Although one
study found the reliability of the MAS to be very good (kappa was 0.84 for interrater and 0.83 for intrarater comparisons)
(Gregson, Leathley, Moore, Sharma, Smith, &Watkins, 1999), other studies found it to be insufﬁcient (Ansari, Naghdi, Arab, &
Jalaie, 2008; Clopton et al., 2005; Mutlu, Livanelioglu, & Gunel, 2008; Yam & Leung, 2006).
Haugh, Pandayan, and Johnson (2006) suggested that the Modiﬁed Tardieu Scale (MTS) is a more appropriate clinical
measure of spasticity than the MAS. The MTS assesses resistance to passive movement at both slow and fast speeds, and
therefore adheres more closely to Lance’s deﬁnition of spasticity (Haugh et al., 2006). Both parameters of the MTS have
excellent intrarater and interrater reliability in children with cerebral palsy (Gracies et al., 2010). However, as with theMAS,
other studies found the MTS to have insufﬁcient reliability (Ansari, Naghdi, Hasson, Azarsa, & Azarnia, 2008; Mackey, Walt,
Lobb, & Stott, 2004; Yam & Leung, 2006).
Both the MTS and the MAS show sufﬁcient interrater and intrarater reliability in adults with intellectual disabilities
(Gielen, 2005), but the MTS seems to be more feasible and reliable than the MAS. The MTS also shows more reliability than
the MAS in adults with severe brain injury and spasticity (Mehrholz et al., 2005). Haugh et al. (2006) stated that further
studies need to be undertaken to clarify the validity and reliability of the MTS and the MAS for a variety of muscle groups in
adult neurological patients. Thus far, no research has been performed to determine the psychometric properties of the MTS
and MAS in persons with PIMD. Therefore, the purpose of this study was to determine the feasibility, test–retest reliability,
and interrater reliability of the MAS and MTS in persons with PIMD.
2. Methods
2.1. Participants
We asked the representatives of 42 persons with PIMD for written permission for these persons to participate in our
study. Forty representatives gavepermission. After informed consentwasobtained, the subjectswere screenedbased onan
examination by both a special needs physician and a behavioral scholar. The screening exclusion criteria were severe
psychological problems or somatic diseases, which were deﬁned as chronic diseases and/or diseases that do not resolve in
the short term. Twopersonswere excludedbecause they exhibited one of these problemsor diseases. The exclusion criteria
at the time the measurements were being performed were general illness or fever; taking antibiotics; recently started
taking muscle relaxants; worsening of asthma, epilepsy (recent insult or epileptic ﬁts); fresh wound(s)/bruise(s) or other
factors causing pain during movement; or stress due to the subject’s behavior just before the measurement date. Three
persons were excluded because they exhibited one of these criteria. Fig. 1 presents the sampling scheme of persons
included in the study.
The participants with PIMDwere classiﬁed as GMFCS IV or V (Palisano et al., 2000). Furthermore, the intellectual level or
intelligence quotient (IQ) of each participant was classiﬁed according to the International Classiﬁcation of Diseases (ICD-10)
of theWorld Health Organization (WHO, 1992). The presence or absence of epilepsy was also recorded, because we assumed
that seizures greatly affect muscle tone. We also classiﬁed the visual impairments of the participants according to WHO
guidelines (WHO, 2001). Finally, the presence or absence of orthopedic disorders was recorded.
2.2. Ethical statement
The studywas performed in agreementwith the guidelines of the Helsinki Declaration as revised in 1975. Permission to
carry out the study was obtained from the institutional ethics committee. Informed consent was obtained from legal
representatives of the participants, because all participants were unable to give consent. The measurements were
performed in accordance with the guidelines of the Dutch Society for Doctors in the Care for people with an Intellectual
Disability (NVAZ), which are outlined in a code called ‘‘Resistance among people with an intellectual disability in the
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framework of the Act GoverningMedical-Scientiﬁc Research Involving Humans’’ (NVAZ, 1999). The purpose of this code is
to guide doctors in assessing resistance in persons with an intellectual disability. In line with this code, a participant’s
consistent distress or unhappiness was interpreted as a sign of lack of assent, and further participation in the study was
reconsidered.
2.3. Design
Themuscle tone and spasticity of 35 participantsweremeasured twice (test and retest) with theMAS andMTS. The retest
was conducted one week after the initial test. The participants were ﬁrst assessed with the MAS and afterwards with the
MTS. For each participant, bothmeasurements were conducted at the same time of day and under the same conditions. Two
observers performed the measurements. The interrater reliability of the MAS and MTS was determined from the
measurements of the two observers. The test–retest reliability of the MAS andMTS was determined by using the test–retest
measurements of observer 1.
2.4. Measures
Prior to the measurements, the observers and personal guides of the participants completed a checklist containing the
exclusion criteria. Both observers were present at the time of the measurements. So that testing would not cause additional
stress to the participants, wemade sure that the participantswere familiarwith observer 2.We created a protocol describing
how to administer the MAS and MTS based on the protocol of Gielen (2005). Gracies et al. (2010) stated that training was
associated with a highly signiﬁcant improvement in reliability, so the observers were trained on how to perform the
protocol. The training consisted of a brief explanation of the protocol and practical exercises. During the practical exercises,
the results were compared and discussed.
2.4.1. Modiﬁed Ashworth Scale (MAS)
TheMAS was carried out as follows. During ﬁve repetitions of a passive motion within one second, resistance was scored
on the following 6-point scale (Bohannon & Smith, 1987):
0 = No increased resistance; 1 = Slightly increased resistance (catch followed by relaxation orminimal resistance at the
end of the range of motion); 1+ = Slightly increased resistance (catch followed by minimal resistance throughout less
than half of the range of motion); 2 = Clear resistance throughout most of the range of motion; 3 = Strong resistance;
passive movement is difﬁcult; 4 = Rigid ﬂexion or extension
Catch is the phenomenon that suddenly a strong resistance occurs during a fast passive movement.
2.4.2. Modiﬁed Tardieu Scale (MTS)
The MTS consists of two measurements: R2 and R1 (Mackey et al., 2004). In the present study, we measured the
most restricted joint motion of both the elbow and the knee. A goniometer was used for measuring the range of motion.
The measurements were accurate to the 5-degree level. The R2 measurement consisted of slow motion performed
within one second. The range of motion was measured with a goniometer. The R1 measurement consisted of fast




2 persons lacked permission from 
representaves 
40 persons 
2 persons excluded for medical/behavioral 
reasons
3 persons excluded at the me of the test  
38 persons 
35 persons 
Fig. 1. Sampling scheme of subjects included in the study.
A. Waninge et al. / Research in Developmental Disabilities 32 (2011) 613–620 615
2.5. Data analyses
The data were analyzed using SPSS 15.0. The distribution of the data was determined and checked for normal
distribution.
2.5.1. Feasibility
To assess feasibility, we compared the number of successful measurements per task to the total number of
measurements. Since it only makes sense to use a test if a reasonable percentage of successful measurements can be made,
this aspect of feasibility was considered to be sufﬁcient if 85% of the measurements were successful (Lemmink, 1996;
Malmberg et al., 2002).
2.5.2. Test–retest reliability
Firstly, to determine whether signiﬁcant differences between test and retest measurements exist, we analyzed the
differences using the t-test or, in case of non-normally distributed data, theWilcoxon signed rank test. The level of statistical
signiﬁcance was set at 0.05.
Secondly, intraclass correlation coefﬁcients (ICC; two-way random, absolute agreement) of measurements 1 and 2 were
computed. Reliability was considered to be acceptable if the ICC was greater than 0.75 and the 95% conﬁdence interval (CI)
was 0.3 or less. Reliability was considered to be very good if the ICC was greater than 0.9 (Portney & Watkins, 2000).
Thirdly, Spearman correlation coefﬁcients of measurements 1 and 2 were computed. Spearman’s correlation was used
because the data were not normally distributed. A correlation of 0.61 or more is considered good (Feinstein, 1987).
Fourthly, for the MTS, limits of agreement (LOA) between measurements 1 and 2 were calculated according to the
procedure described by Bland and Altman (1986). LOAs were expressed together with the mean differences between
measurements 1 and 2, and were judged whether they were narrow enough for the test to be of practical use, according to
Atkinson and Nevill (1998). For the MAS, quadratically weighted kappa for measurements 1 and 2 was calculated. The
quadratically weighted kappa is a measure of the proportion of agreement greater than that expected by chance. Values of
kappa below0.40 are generally considered to be clinically unacceptable, thosewithin 0.41–0.60 to bemoderate, thosewithin
0.61–0.80 to be substantial, and those 0.81–1.00 to be almost perfect (Sim & Wright, 2005). To obtain 95% (CIs) for the
weighted kappa coefﬁcients, we used the adjusted bootstrap percentile (BCa)method (Davison&Hinkley, 1997; Efron, 1987)
by employing the statistical programming language R (R Development Core Team, 2009).
Finally, the test–retest reliability of the MTS was considered reliable if (1) there were no signiﬁcant differences between
the test and retest measurements; (2) ICC was acceptable, as described above; (3) Spearman correlation coefﬁcient was
acceptable, as described above; and (4) LOA was acceptable, as described above. The test–retest reliability of the MAS was
considered reliable if (1) there were no signiﬁcant differences between the test and retest measurements; (2) ICC was
acceptable, as described above; (3) Spearman correlation coefﬁcient was acceptable, as described above; and (4)
quadratically weighted kappa was almost perfect, with a 95% CI from substantial to almost perfect, as described above.
2.5.3. Interrater reliability
Firstly, to determine whether signiﬁcant differences between the measurements of observers 1 and 2 exist, we analyzed
the differences across measurements using a t-test or, in case of non-normally distributed data, the Wilcoxon signed rank
test. The level of statistical signiﬁcance was set at 0.05.
Secondly, the ICCs (two-way random, absolute agreement) of the measurements of observers 1 and 2 were computed.
Reliability was considered to be acceptable if the ICC was greater than 0.75. Reliability was considered to be very good if the
ICC was greater than 0.9 (Portney & Watkins, 2000).
Thirdly, Spearman correlation coefﬁcients of the measurements of observers 1 and 2 were computed. Spearman’s
correlation was used because the data were not normally distributed. A correlation of 0.61 or more is considered good
(Feinstein, 1987).
Fourthly, for the MTS, LOAs between the measurements of observer 1 and 2 were calculated according to the procedure
described by Bland andAltman (1986). LOAswere expressed togetherwith themean differences between themeasurements
of observers 1 and 2, and were judged whether they were narrow enough for the test to be of practical use, according to
Atkinson and Nevill (1998). For the MAS, quadratically weighted kappa for the measurements of observers 1 and 2 was
calculated. Values of kappa below 0.40 are generally considered to be clinically unacceptable, those within 0.41–0.60 to be
moderate, those within 0.61–0.80 to be substantial, and those within 0.81–1.00 to be almost perfect (Sim & Wright, 2005).
We calculated 95% (CIs) for the weighted kappa coefﬁcients (adjusted BCa method) (Davison & Hinkley, 1997; Efron, 1987)
by employing the statistical programming language R (R Development Core Team, 2009).
Finally, the interrater reliability of theMTSwas considered acceptable if (1) therewere no signiﬁcant differences between
the measurements of observers 1 and 2; (2) LOA was acceptable, as described above; (3) Spearman correlation coefﬁcient
was acceptable as described above; and (4) ICC was acceptable, as described above. The interrater reliability of the MAS was
considered reliable if (1) there were no signiﬁcant differences between the measurements of observers 1 and 2; (2) ICC was
acceptable, as described above; (3) Spearman correlation coefﬁcient was acceptable, as described above; and (4)
quadratically weighted kappa was almost perfect, with a 95% CI from substantial to almost perfect, as described above.
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3. Results
The data were not normally distributed; therefore, non-parametric tests were used to analyze the data. In all, 35 subjects
participated in this study; 22 were male (62.9%), and 13 were female (37.1%). The mean age (SD) of the men was 35 (15)
years, and that of the women was 31 (12) years. The characteristics of the study population are shown in Table 1.
3.1. Feasibility
3.1.1. Percentage of successful measurements
The percentages of successful measurements are shown in Table 2. Both theMAS andMTS showed a sufﬁcient percentage
of successful measurements.
3.2. Test–retest reliability of the MTS
Table 3 summarizes the statistical analyses for measurements 1 and 2 of the MTS.
There were no signiﬁcant differences between measurements 1 and 2 (p< 0.05). The ICC showed acceptable
agreement for the R2 measurement of the arm and the R1 measurement of the leg. The ICC for the R1 measurement of the
arm and the R2 measurement of the leg was not acceptable. The LOAs for both arm and leg measurements compared to
median values were considerably large, which is clinically unacceptable. The Spearman correlation coefﬁcient showed
good correlation between the test–retest measurements for both arm and leg, except for the R2 measurement of the leg
which was not acceptable.
3.3. Test–retest reliability of the MAS
Table 4 summarizes the statistical analyses for measurements 1 and 2 of the MAS.
There were no signiﬁcant differences between measurements 1 and 2 (p< 0.05). The ICC showed acceptable
agreement between MAS measurements 1 and 2 for the arm and leg. The quadratically weighted kappa was almost
perfect for the arm measurements and substantial for the leg measurements; the 95% CI values were substantial to
Table 1











Severe 22 Blind/severe 25 Level 4 11 Yes 17 Yes 30 Yes 32
Profound 13 Partially 10 Level 5 24 No 18 No 5 No 3
Table 3















Arm R2 34 30 (0–95) 32.50 (0–95) 0.592 0.815 2.353  35.2 0.792
Arm R1 34 55 (0–100) 57.50 (0–90) 0.890 0.627 6.029  57.7 0.624
Leg R2 33 70 (0–135) 70 (0–120) 0.779 0.741 1.818  44 0.402
Leg R1 33 67.50 (0–110) 75 (0–115) 0.089 0.850 5.75  29.8 0.680
Table 2
Percentages of successful measurements for the MTS and MAS.
Successful measurements week 1 Successful measurements week 2
Observer 1 Observer 1
Modiﬁed Tardieu Scale (MTS)
Arm R2 100% 97.1%
Arm R1 100% 97.1%
Leg R2 97.1% 94.3%
Leg R1 97.1% 94.3%
Modiﬁed Ashworth Scale (MAS)
Arm 100% 97.1%
Leg 97.1% 94.3%
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almost perfect. The Spearman correlation coefﬁcient demonstrated clear agreement between measurements 1 and 2 for
the arm and leg.
3.4. Interrater reliability of the MTS
Table 5 summarizes the statistical analyses for the MTS measurements of observers 1 and 2. There were no signiﬁcant
differences between the measurements made by observers 1 and 2 (p< 0.05). The ICC showed acceptable agreement
between all the R2 and R1 measurements of observer 1 and 2. The LOAs of both arm and leg measurements compared to
median values were considerably large, which is clinically not acceptable. The Spearman correlation coefﬁcients between
the R2 and R1 measurements of observer 1 and 2 were acceptable.
3.5. Interrater reliability of the MAS
Table 6 summarizes the statistical analyses for MAS measurements of observers 1 and 2. There were no signiﬁcant
differences between the measurements taken by observers 1 and 2 (p< 0.05). The ICC shows an acceptable agreement
between the measurements of the arm and the leg of observers 1 and 2. The quadratically weighted kappa is almost perfect
for the measurements of observers 1 and 2 of both the arm and the leg, the 95% CI are substantial to almost perfect. The
Spearman correlation coefﬁcient between the measurements of the arm and the leg of observers 1 and 2 is acceptable.
4. Discussion
Thepurposeof our studywas todetermine the feasibility, the test–retest reliability, and interrater reliability of theMAS and
MTS in persons with PIMD. Our results demonstrated that the feasibility of the measurements was good, as an acceptable
percentage of successfulmeasurementswere performed. The interrater reliability of theMASwas sufﬁcient,with a substantial
to almost perfect quadratically weighted kappa and an acceptable ICC. However, we found the reliability of the MTS not to be
clinically acceptable. Although the ICC indicated that the interrater reliability of theMTSwas sufﬁcient, the LOAs for both arm
and leg measurements relative to median values were considerably large, which is clinically not acceptable.
TheMAS showed a sufﬁcient test–retest reliability, with a substantial to almost perfect quadraticallyweighted kappa and
an acceptable ICC. However, the test–retest reliability of the MTS was not sufﬁcient due to its insufﬁcient ICC, Spearman’s
correlations, and clinically unacceptable LOAs for both arm and leg measurements.
In our target group, the MAS showed a better test–retest and interrater reliability than the MTS, which contradicts the
results of Gielen (2005) and Mehrholz et al. (2005). In the study of Gielen (2005), for the MAS the test–retest reliability
Table 6













































Arm R2 24 30 (0–95) 30 (0–110) 0.886 0.806 0.00 40 0.813
Arm R1 24 55 (0–100) 70 (0–100) 0.540 0.851 5.870 38 0.825
Leg R2 23 70 (0–135) 60 (0–115) 0.730 0.766 0.91 54 0.696
Leg R1 23 67.50 (0–110) 60 (0–120) 0.924 0.877 0.45 60 0.726
Table 4
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calculated with Spearman’s rho ranged from 0.66 to 0.81 (our study: 0.76–0.86) and the interrater reliability from 0.67 to
0.80 (our study: 0.86–0.91). For theMTS, Gielen’s Spearman’s rhowas slightly better, with a range of 0.70–0.88 for intrarater
reliability (our study: 0.40–0.79) and 0.70–0.82 for interrater reliability (our study: 0.70–0.83). As mentioned in the
introduction, these contradictory ﬁndings also occurred in other target groups. All participants in our study population had
impaired vision. Impaired visionmay have contributed to differences in the fastermovements of theMTS R2measurements.
Our subjects could not anticipate fast movements as well as their peers without visual impairments.
Compared to the study of Clopton et al. (2005) in children with hypertonia, our ICC values for the MAS (0.81–0.85 for
intrarater; 0.89–0.89 for interrater) were more sufﬁcient than their ICC values (0.5–0.75 for intrarater; <0.5 for interrater).
Mutlu et al. (2008) performed a reliability study of the MAS in children with spastic cerebral palsy and found an intrarater
reliability of 0.36–0.83 (ICC) and an interrater reliability of 0.54–0.78 (ICC), which is also less reliable than our ICC values for
the MAS.
Our quadratically weighted kappa score for the intrarater reliability of the MAS was higher (interrater reliability 0.88;
intrarater reliability 0.78–0.82) than the kappa (interrater reliability 0.51; intrarater reliability 0.59) of Ansari, Naghdi, Arab,
et al. (2008), which tested the MAS in persons with hemiplegia. In the study of Gregson et al. (1999), which involved post-
stroke patients, the kappa score for interrater reliability was 0.84 and for intrarater reliability was 0.83, which is comparable
to the quadratically weighted kappa scores of the present study.
In our target group, theMTS had ICCs of 0.76–0.88 for interrater reliability and 0.63–0.85 for intrarater reliability, which is
better than the interrater scores of Ansari, Naghdi, Hasson, et al. (2008) in patientswith hemiplegia (<0.56). In general, in the
present study the interrater reliability of the MTS was better than the intrarater reliability. This difference may be due to
changes in the condition of the participants at the time of the two measurements. This premise is also supported by the
relatively large LOA outcomes, which indicated that there was too much variation at the individual level. The LOAs for both
arm and leg measurements compared to median values was considerably large; most of the measurements departed more
than 50% from the median. The LOAs were not narrow enough to indicate agreement between the two measurements of an
individual. Therefore, we concluded that the LOAs for the MTS measurements were clinically unacceptable. Haugh et al.
(2006) suggested that the MTS is a more appropriate clinical measure of spasticity than the MAS. Therefore, we determined
whether the LOA for MTS measurements of persons with spasticity was less than the LOA for measurements of persons
without spasticity. However, the LOAs did not differ between these groups.
The purpose of our study was to determine the feasibility and reliability of the MAS and MTS in persons with PIMD.
However, the validity of these instruments formeasuring either spasticity ormuscle tonewas beyond the scope of this study.
After the start of our study a manuscript was published entitled, ‘‘Stop using the Ashworth Scale for the assessment of
spasticity’’ (Fleuren et al., 2010). Taking their paper into account, we recommend that the validity of the MAS be examined
further in future studies. Doing so, however, raises the issue of which speciﬁc parameter must be examined—the validity of
measuring spasticity or the validity of measuring the quality of daily movements—since the MAS may be more suitable for
measuring the latter. Ghotbi et al. (2009) also obtained reliable measurements with the Modiﬁed Ashworth Scale,
supporting the recommendation that further research should be done on this instrument.
Given the outcomes of the ICC, quadratically weighted kappa, and the Spearman’s correlation for the MAS compared to
corresponding values obtained by other studies, the interrater and intrarater reliability of theMAS are sufﬁcient in this target
group. Furthermore, the usability of the MAS and MTS according to the observers appeared to be good. The protocol
developed for the study functioned well for the observers. The observers were able to perform the tests properly after
receiving training on the test protocol. The instructions were clear, and other physical therapists were able to follow the test
protocol. The instruments also ﬁt well within physical therapy. Moreover, testing was brief and the instruments were
inexpensive.
5. Conclusions
Our research showed that the feasibility of using the MAS and MTS for measuring muscle tone in persons with PIMD is
good. In our participants, the MAS showed sufﬁcient test–retest and interrater reliability, whereas the MTS showed
insufﬁcient test–retest and interrater reliability. Therefore, theMASmay be a goodmethod for evaluating the quality of daily
movements in individuals with PIMD. Providing training and clear instructions on administering the MAS will improve
reliability. Further research should aim to examine the validity of the MAS.
6. Recommendations
The feasibility of conducting MAS and MTS measurements in persons with PIMD is good. Adjustments in implementing
the MAS and MTS are not necessary. Further research involving more participants may provide additional information.
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